Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: Association with gallbladder cancer susceptibility

International Journal of Gastrointestinal Cancer

Volumn 37, Issue 4, 2006, Pages 124-128

  Pandey, Sachchida Nand ^a   Dixit, Manjusha ^a   Choudhuri, Gourdas ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cholesterol; Gallbladder cancer; Gallstone; Genetic polymorphism; Lipoprotein receptor associated protein; Receptor associated protein

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHOLELITHIASIS; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SEQUENCE DELETION;

EID: 42149084891     PISSN: 15373649     EISSN: 15590739     Source Type: Journal    
DOI: 10.1007/s12029-007-9002-y     Document Type: Article

References (17)

1. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-76.
2. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349-64.
3. Mohr GC, Kritz-Silverstein D, Barrette-Connor E. Plasma lipid and gallbladder disease. Am J Epidemiol. 1991;134:78-85.
4. Thijis C, Knipschild P, Brombacher P. Serum lipid and gallstones: a case control study. Gastroenterology. 1999;99:843-9.
5. Scragg RK, McMicheal AJ, Baghurst PA. Diet alcohol and relative weight in gallstone disease: a case-control study. Br Med J. 1984;288:1113-8.
6. Willnow TE, Rohlmann A, Horton J, Otani H, Braun JR, Hammer RE et al. RAP a specialized chaperone, prevent ligand-induced ER retention and degradation of LDL receptor-related endocytic receptor. EMBO J. 1996;15:2632-9.
7. Korenberg JR, Argraves KM, Chen XN, Tran H, Strickland DK, Argraves WS. Chromosoma localization of human genes for the LDL receptor gene family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1). Genomics. 1994;22:88-93.
8. Bense P, Muzik J, Benedik J, Elbl L, Znojil V, Vacha J. Relation between the insertion/deletion polymorphism in the gene encoding for receptor associated protein (RAP) and plasma apolipoprotein A-I (Apo A-I) and high density lipoprotein cholesterol (HDL) levels. Clin Genet. 2000;57:309-10.
9. Schutte DL, Mass M, Buckwalter KC. A LRPAP1 intronic insertion/deletion polymorphism and phenotypic variability in Alzheimer disease. Res Theory Nurs Pract. 2003;17:301-19.
10. Dixit M, Choudhuri G, Kesari LJ, Mittal B. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J Gastroenterol Hepatol. 2006;21:847-9.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
12. Tosia MR, Tugnoli V. Cholesteryl esters in malignancy. Clinica Chimica Acta. 2005;359:27-45.
13. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 2007;28:1637-43.
14. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM et al. Frequent translocation (4; 14) (p16.3; q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet. 1997;16:260-4.
15. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet. 1999;23:18-20.
16. Gillmer MD. Mechanism of action/effects of androgens on lipid metabolism. Int J Fertil. 1992;37:83-92.
17. Sarrel PM. Cardiovascular aspects of androgens in women. Semin Reprod Endocrinol. 1998;16:121-8.